RA Capital Biotech Fund, LP Urges Board of Northstar Neuroscience, Inc. to Maximize Value to Shareholders by Reducing Expenses and Either Finding a Buyer or Making a Cash Distribution

Published: Jul 14, 2008

BOSTON--(BUSINESS WIRE)--RA Capital Biotech Fund, LP today announced that it has sent the Board of Directors of Northstar Neuroscience, Inc. (NASDAQ: NSTR) a letter urging that, to maximize shareholder value, they reduce operating expenses immediately and either find a buyer or make a cash distribution. The text of the letter sent to the Northstar Board of Directors follows.

Back to news